ISO 13485 is the internationally recognized quality standard for the medical device industry. A translation vendor needs ISO 13485 certification to ensure their Quality Management System (QMS) aligns seamlessly with the rigorous risk management, traceability, and compliance standards of medical device manufacturers. It guarantees that localized content, such as Instructions for Use (IFUs) and software interfaces, is handled with the same level of quality control as the manufacturing of the physical device itself.

In the global medical device sector, the physical hardware is only one component of the product. The software interface, the labeling, the packaging, and the Instructions for Use (IFUs) are legally and functionally considered part of the medical device. Therefore, a flaw in the translated IFU is treated by regulatory bodies with the same severity as a mechanical failure in the device itself. This reality underscores the critical importance of ISO 13485.

While many translation agencies boast general quality certifications like ISO 9001, the medical device industry requires a deeper, more specialized level of rigor. ISO 13485:2016 outlines the requirements for a comprehensive Quality Management System (QMS) specifically tailored to the design and manufacture of medical devices. But why does a company that simply translates text need a manufacturing standard?

When a medical device manufacturer outsources translation, they are outsourcing a critical step in the product realization process. Under ISO 13485, manufacturers are responsible for the control of their outsourced processes (Clause 4.1.5) and purchasing controls (Clause 7.4). If a manufacturer partners with a localization vendor that does not understand or operate under a compatible QMS, the manufacturer assumes a massive burden of auditing, micro-managing, and risking non-compliance.

An ISO 13485-certified language service provider integrates perfectly into the manufacturer’s supply chain. It means the vendor speaks the same language of quality, compliance, and risk management.

ISO 13485 ClauseApplication to Translation and Localization
Clause 4.2.3: Document ControlEnsures exact versioning of source and translated files. Prevents an obsolete, previously translated IFU from being published.
Clause 7.1: Risk Management (via ISO 14971)Identifying localization risks (e.g., text expansion in UI, regional terminology shifts) and mitigating them before translation begins.
Clause 8.5.2: CAPA (Corrective and Preventive Action)If a linguistic error is discovered, the vendor has a formal, auditable process to find the root cause and prevent recurrence, aligning with FDA 21 CFR Part 820.
Clause 6.2: Human ResourcesMandates documented proof that linguists and project managers are competent, trained, and qualified for medical translation.

Choosing a non-certified translation partner to save on initial costs is a false economy. The consequences of localization errors include regulatory rejections, delayed product launches, expensive product recalls, and, most critically, compromised patient safety. When an auditor from a Notified Body reviews your technical file, they will scrutinize your localized labels. Having an ISO 13485-certified localization partner provides a defensible, transparent, and proven audit trail.

What is the difference between ISO 9001 and ISO 13485?

ISO 9001 is a general quality management standard focused on continuous improvement and customer satisfaction across any industry. ISO 13485 is specific to medical devices, focusing heavily on regulatory compliance, risk management, and maintaining the safety and efficacy of the product.

Does the FDA require translation vendors to have ISO 13485?

While the FDA does not explicitly mandate that vendors hold ISO 13485 certification, the FDA’s Quality System Regulation (21 CFR Part 820) closely aligns with ISO 13485. Manufacturers must control their suppliers, and using an ISO 13485-certified vendor satisfies these strict supplier control requirements.

At Ingenuiti, we recognize that we are not just translating words; we are localizing critical medical tools. Our adherence to stringent quality standards means that our processes are built to handle the unique pressures of the medical device lifecycle. By choosing a partner steeped in the rigorous nature of ISO 13485, medical device companies can confidently expand into global markets, knowing their localized assets meet the highest standards of safety and compliance.

Mitigate audit risk with an ISO 13485-certified localization partner. Ensure your IFUs, UI, and labeling meet strict FDA and EU MDR standards. Connect with our medical translation team today. Get a free quote for quality-focused translation support

Picture of Adam Eling

Adam Eling

Adam Eling is the Vice President of Client Services at Ingenuiti, where he leverages over 15 years of expertise to drive global learning strategies. A seasoned speaker and industry thought leader, Adam is recognized for his "curiosity-first" approach to solving complex L&D challenges. Based in Charleston, SC, he balances his passion for the evolving education landscape with family time, hiking, and the outdoors.

Share on social:

Contact
Ingenuiti Today

Schedule a free, 15-minute discovery call to discuss your needs.